Anaplastic Gliomas With 1p/19q Codeletion

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Anaplastic Gliomas With 1p/19q Codeletion trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

All recent trials (2 shown)

CompletedPhase 3

NCT02444000

gliomasPCV Only in 1p/19q Codeleted Anaplastic Gliomas

Patients with 1p/19q-codeleted anaplastic gliomas treated with RT + PCV are at risk of neurocognitive deterioration. Treating these patients with PCV alone (cou…

France280 participantsStarted 2015-09-22

Treatment: PCV chemotherapy alone, Radiotherapy+PCV chemotherapy

UnknownPhase 2

NCT01534845

Efficacy Study of Radiotherapy Alone Versus CCRT With Temozolomide in Grade III Gliomas Without 1p/19q Codeletion

1. The management of anaplastic gliomas of WHO grade 3 is currently largely based on surgery followed by radiotherapy, of which prognosis remains still dismal w…

South Korea90 participantsStarted 2012-03

Treatment: Temozolomide (Temodal)